Generation of a recombinant rabies virus expressing green fluorescent protein for a virus neutralization antibody assay
Dong-Kun YANG; Ha-Hyun KIM; Yu-Ri PARK; Jae-Young YOO; Yeseul PARK; Jungwon PARK; Bang-Hun HYUN.
Journal of Veterinary Science
; : e56-2021.
Artículo
en Inglés
| WPRIM | ID: wpr-901426
Background@#Fluorescent antibody virus neutralization (FAVN) test is a standard assay for quantifying rabies virus-neutralizing antibody (VNA) in serum. However, a safer rabies virus (RABV) should be used in the FAVN assay. There is a need for a new method that is economical and time-saving by eliminating the immunostaining step. @*Objectives@#We aimed to improve the traditional FAVN method by rescuing and characterizing a new recombinant RABV expressing green fluorescent protein (GFP). @*Methods@#A new recombinant RABV expressing GFP designated as ERAGS-GFP was rescued using a reverse genetic system. Immuno-fluorescence assay, peroxidase-linked assay, electron microscopy and reverse transcription polymerase chain reaction were performed to confirm the recombinant ERAGS-GFP virus as a RABV expressing the GFP gene. The safety of ERAGS-GFP was evaluated in 4-week-old mice. The rabies VNA titers were measured and compared with conventional FAVN and FAVN-GFP tests using VERO cells. @*Results@#The virus propagated in VERO cells was confirmed as RABV expressing GFP.The ERAGS-GFP showed the highest titer (108.0TCID50/mL) in VERO cells at 5 days postinoculation, and GFP expression persisted until passage 30. The body weight of 4-week-old mice inoculated intracranially with ERAGS-GFP continued to increase and the survival rate was 100%. In 62 dog sera, the FAVN-GFP result was significantly correlated with that of conventional FAVN (r = 0.95). @*Conclusions@#We constructed ERAGS-GFP, which could replace the challenge virus standard-11 strain used in FAVN test.
Biblioteca responsable:
WPRO
Texto completo
Documentos relacionados